Bone Biologics Corporation (BBLG)Healthcare | Biotechnology | Burlington, United States | NasdaqCM
0.62 USD
0.00
(-0.033%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.61 0.00 (-0.005%) ⇩ (Aug. 28, 2026, 7:44 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:38 a.m. EDT
The immediate outlook is severely compromised by a violent breakdown in price action. After trading near $1.00 earlier in the session, the stock collapsed to $0.61 within days, erasing nearly 40% of its value in a single week. This freefall has dragged the price well below its 50-day and 200-day moving averages, creating a massive technical gap that suggests sellers are in complete control. While the company recently extended the shelf life of its rhNELL-1 product and secured additional funding to extend its runway to 2027, these operational milestones failed to arrest the bleeding in the market. The disconnect between the 'strong buy' analyst recommendation and the reality of a stock trading at less than 30% of its book value indicates a profound lack of confidence in the near-term catalysts. With no earnings growth to speak of and a history of massive annual declines, there is no foundation for a recovery trade at these levels. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.330713 |
| AutoTheta | 0.348766 |
| AutoETS | 0.349180 |
| MSTL | 0.351435 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 31% |
| H-stat | 139.31 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.148 |
| Excess Kurtosis | -1.29 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 1,694,975 |
| Forward P/E | -0.92 |
| Beta | 0.53 |
| Website | https://www.bonebiologics.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.7099056 |
| Address1 | 2 Burlington Woods Drive |
| Address2 | Suite 100 |
| All Time High | 10,255.68 |
| All Time Low | 0.58 |
| Ask | 0.7566 |
| Ask Size | 2 |
| Average Analyst Rating | 0.0 - Strong Buy |
| Average Daily Volume10 Day | 104,080 |
| Average Daily Volume3 Month | 336,014 |
| Average Volume | 336,014 |
| Average Volume10Days | 104,080 |
| Beta | 0.53 |
| Bid | 0.42 |
| Bid Size | 2 |
| Book Value | 2.168 |
| City | Burlington |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.615 |
| Current Ratio | 8.665 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.615 |
| Day Low | 0.5801 |
| Display Name | Bone Biologics |
| Dividend Date | 1,532,390,400 |
| Earnings Timestamp End | 1,754,942,400 |
| Earnings Timestamp Start | 1,754,596,800 |
| Ebitda Margins | 0.0 |
| Enterprise Value | -2,336,805 |
| Eps Current Year | -1.23 |
| Eps Forward | -0.67 |
| Eps Trailing Twelve Months | -0.28 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.05356 |
| Fifty Day Average Change | -0.43856 |
| Fifty Day Average Change Percent | -0.41626486 |
| Fifty Two Week Change Percent | -70.99056 |
| Fifty Two Week High | 4.13 |
| Fifty Two Week High Change | -3.515 |
| Fifty Two Week High Change Percent | -0.8510896 |
| Fifty Two Week Low | 0.58 |
| Fifty Two Week Low Change | 0.035000026 |
| Fifty Two Week Low Change Percent | 0.060344875 |
| Fifty Two Week Range | 0.58 - 4.13 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,634,131,800,000 |
| Float Shares | 2,755,396 |
| Forward Eps | -0.67 |
| Forward P E | -0.91791046 |
| Free Cashflow | -1,686,114 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 2 |
| Fullday Change | -0.000199974 |
| Fullday Change Percent | -0.0325055 |
| Fullday Price | 0.61 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.00024000001 |
| Held Percent Institutions | 0.009509999 |
| Implied Shares Outstanding | 2,756,057 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-10-13 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,749,513,600 |
| Last Split Factor | 1:6 |
| Long Business Summary | Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts. |
| Long Name | Bone Biologics Corporation |
| Market | us_market |
| Market Cap | 1,694,975 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_99330767 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -2,891,070 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,695,526 |
| Number Of Analyst Opinions | 1 |
| Open | 0.6076 |
| Operating Cashflow | -2,628,868 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 781 552 4452 |
| Post Market Change | -0.004999995 |
| Post Market Change Percent | -0.81300735 |
| Post Market Price | 0.61 |
| Post Market Time | 1,787,960,654 |
| Previous Close | 0.6152 |
| Price Eps Current Year | -0.5 |
| Price Hint | 4 |
| Price To Book | 0.2836716 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.888 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 0.0 |
| Region | US |
| Regular Market Change | -0.000199974 |
| Regular Market Change Percent | -0.0325055 |
| Regular Market Day High | 0.615 |
| Regular Market Day Low | 0.5801 |
| Regular Market Day Range | 0.5801 - 0.615 |
| Regular Market Open | 0.6076 |
| Regular Market Previous Close | 0.6152 |
| Regular Market Price | 0.615 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 27,901 |
| Return On Assets | -0.33455002 |
| Return On Equity | -0.5496 |
| Sand P52 Week Change | 0.1966995 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 2,756,057 |
| Shares Percent Shares Out | 0.056799997 |
| Shares Short | 156,590 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 26,560 |
| Short Name | Bone Biologics Corp |
| Short Percent Of Float | 0.056799997 |
| Short Ratio | 0.22 |
| Source Interval | 15 |
| State | MA |
| Symbol | BBLG |
| Target High Price | 12.2 |
| Target Low Price | 12.2 |
| Target Mean Price | 12.2 |
| Target Median Price | 12.2 |
| Total Cash | 4,031,780 |
| Total Cash Per Share | 1.463 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.28 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.33402 |
| Two Hundred Day Average Change | -0.71902 |
| Two Hundred Day Average Change Percent | -0.5389874 |
| Type Disp | Equity |
| Volume | 27,901 |
| Website | https://www.bonebiologics.com |
| Zip | 1,803 |